Aveanna Healthcare Reports Strong Q1 Results, Raises Full-Year 2026 Revenue and EBITDA Guidance

summarizeSummary

Aveanna Healthcare reported strong first-quarter financial results, with significant increases in revenue and profitability, and subsequently raised its full-year 2026 guidance.

check_boxKey Events

• Strong Q1 2026 Financial Performance

  Revenue increased by 15.9% to $647.9 million, net income surged to $41.7 million from $5.2 million in the prior year, and Adjusted EBITDA grew by 25.2% to $84.4 million.

• Raised Full-Year 2026 Guidance

  The company increased its full-year 2026 revenue guidance to between $2.56 and $2.58 billion (from $2.54 - $2.56 billion) and Adjusted EBITDA guidance to between $328 and $332 million (from $318 - $322 million).

• Positive Organic Growth

  CEO Jeff Shaner highlighted the strength and resiliency of the business model, noting that the revised guidance reflects positive momentum and excludes the pending Family First Homecare acquisition.

auto_awesomeAnalysis

Aveanna Healthcare delivered a strong first quarter, significantly increasing revenue, net income, and Adjusted EBITDA year-over-year. The company also raised its full-year 2026 guidance for both revenue and Adjusted EBITDA, signaling positive momentum and confidence in its business model. This strong performance, which excludes the pending Family First Homecare acquisition, indicates robust organic growth and improved profitability.